<DOC>
	<DOCNO>NCT01768247</DOCNO>
	<brief_summary>A thin endometrium one difficult problem encounter assist reproduction every day practice Regarding proliferative phase , several way treatment undertaken circumvent thin endometrium try increase thickness questionable result . The objective current study whether daily dose 150 IU ( international unit ) human chorionic gonadotropin ( HCG ) seven day concomitant estrogen administration estrogen replacement cycle increase endometrial thickness improve pregnancy outcome .</brief_summary>
	<brief_title>HCG ( Human Chorionic Gonadotropin ) Priming Thin Endometrium IVF ( Vitro Fertilization )</brief_title>
	<detailed_description>In pilot study subject repeatedly resistant thin endometrium , less 6mm , recruit . The investigator seek investigate possible role add low dose HCG follicular phase , endometrial growth development . The investigator construct hypothesis base fact LH/HCG ( luteinizing hormone/human chorionic gonadotropin ) receptor present endometrium therefore positive interaction could anticipate HCG administer proliferative phase endometrial growth . Furthermore , previous study , human menopausal gonadotropin ( hMG ) -well know render luteinizing hormone ( LH ) capacity due low dose HCG contain- compare recombinant-follicular stimulate hormone ( rec-FSH ) ovarian stimulation , endometrium likely iso-echogenic hypo-echogenic hMG group , also anticipate possible positive role HCG activity .</detailed_description>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<criteria>( 1 ) Less 6mm endometrial thickness , ( 2 ) least two fail implantation Abnormal uterine cavity Hysteroscopy</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>endometrium</keyword>
	<keyword>thickness</keyword>
	<keyword>pregnancy</keyword>
	<keyword>HCG</keyword>
	<keyword>frozen cycle</keyword>
</DOC>